Troyer DA - Search Results

1

Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy.

Eng SE, Basasie B, Lam A, John Semmes O, Troyer DA, Clarke GD, Sunnapwar AG, Leach RJ, Johnson-Pais TL, Sokoll LJ, Chan DW, Tosoian JJ, Siddiqui J, Chinnaiyan AM, Thompson IM Jr, Boutros PC, Liss MA. Eng SE, et al. Among authors: troyer da. Prostate Cancer Prostatic Dis. 2024 Mar;27(1):65-72. doi: 10.1038/s41391-022-00591-w. Epub 2022 Sep 12. Prostate Cancer Prostatic Dis. 2024. PMID: 36097168

2

Prostate cancer prevention: what do we know now and when will we know more?

Thompson IM, Basler J, Hensley D, von Merveldt D, Jenkins CA, Higgins B, Leach R, Troyer D, Pollock B. Thompson IM, et al. Clin Prostate Cancer. 2003 Mar;1(4):215-20. doi: 10.3816/cgc.2003.n.002. Clin Prostate Cancer. 2003. PMID: 15040879 Review.

3

Restriction Spectrum Imaging-Magnetic Resonance Imaging to Improve Prostate Cancer Imaging in Men on Active Surveillance.

Besasie BD, Sunnapwar AG, Gao F, Troyer D, Clarke GD, White H, Fox PT, Dale A, Wheeler A, Liss MA. Besasie BD, et al. J Urol. 2021 Jul;206(1):44-51. doi: 10.1097/JU.0000000000001692. Epub 2021 Feb 22. J Urol. 2021. PMID: 33617334

4

A copy number gain on 18q present in primary prostate tumors is associated with metastatic outcome.

Ashcraft KA, Johnson-Pais TL, Troyer DA, Hernandez J, Leach RJ. Ashcraft KA, et al. Among authors: troyer da. Urol Oncol. 2020 Dec;38(12):932.e1-932.e7. doi: 10.1016/j.urolonc.2020.06.015. Epub 2020 Jul 12. Urol Oncol. 2020. PMID: 32665124 Free PMC article.

5

Assessment of 54 biomarkers for biopsy-detectable prostate cancer.

Parekh DJ, Ankerst DP, Baillargeon J, Higgins B, Platz EA, Troyer D, Hernandez J, Leach RJ, Lokshin A, Thompson IM. Parekh DJ, et al. Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):1966-72. doi: 10.1158/1055-9965.EPI-07-0302. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17932343

6

Biomarkers for prostate cancer detection.

Parekh DJ, Ankerst DP, Troyer D, Srivastava S, Thompson IM. Parekh DJ, et al. J Urol. 2007 Dec;178(6):2252-9. doi: 10.1016/j.juro.2007.08.055. Epub 2007 Oct 22. J Urol. 2007. PMID: 17936845 Review.

7

Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans.

Shook SJ, Beuten J, Torkko KC, Johnson-Pais TL, Troyer DA, Thompson IM, Leach RJ. Shook SJ, et al. Among authors: troyer da. Clin Cancer Res. 2007 Oct 1;13(19):5959-64. doi: 10.1158/1078-0432.CCR-07-0702. Clin Cancer Res. 2007. PMID: 17908993

8

Association of polymorphisms in TGFB1 and prostate cancer prognosis.

Brand TC, Bermejo C, Canby-Hagino E, Troyer DA, Baillargeon J, Thompson IM, Leach RJ, Naylor SL. Brand TC, et al. Among authors: troyer da. J Urol. 2008 Feb;179(2):754-8. doi: 10.1016/j.juro.2007.09.020. Epub 2007 Dec 20. J Urol. 2008. PMID: 18082198

9

Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men.

Balic I, Graham ST, Troyer DA, Higgins BA, Pollock BH, Johnson-Pais TL, Thompson IM, Leach RJ. Balic I, et al. Among authors: troyer da. J Urol. 2002 Nov;168(5):2245-8. doi: 10.1016/S0022-5347(05)64364-9. J Urol. 2002. PMID: 12394768

10

Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridization.

Vijayakumar S, Hall DC, Reveles XT, Troyer DA, Thompson IM, Garcia D, Xiang R, Leach RJ, Johnson-Pais TL, Naylor SL. Vijayakumar S, et al. Among authors: troyer da. Cancer Res. 2006 Apr 15;66(8):4055-64. doi: 10.1158/0008-5472.CAN-05-3822. Cancer Res. 2006. PMID: 16618725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page